Cutaneous T-Cell Lymphomas: Prognosis and Quality-of-Life Issues

Clinical Lymphoma

Volumn 1, Issue 1 SUPPL., 2000, Pages

  Dummer, Reinhard ^a   Hess Schmid, Monika ^a   Burg, Günter ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cutaneous T cell lymphomas; EORTC classification; Epidemiology; Etiology

Indexed keywords

CLASSIFICATION; CUTANEOUS T CELL LYMPHOMA; HUMAN; PROGNOSIS; QUALITY OF LIFE; REVIEW; SKIN TUMOR;

HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; PROGNOSIS; QUALITY OF LIFE; SKIN NEOPLASMS;

EID: 0008808964     PISSN: 15269655     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2000.s.004     Document Type: Article

References (30)

1. Davis TH, Morton CC, Miller-Cassman R, et al. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 1992; 326:1115-1122.
2. Edelson RL. Cutaneous T cell lymphoma: mycosis fungoides, Sezary syndrome, and other variants. J Am Acad Dermatol 1980; 2:89-106.
3. Clendenning WE. Mycosis fungoides. History, clinical features, controversies. Bull Cancer 1977; 64:167-176.
4. Thomsen K. Scandinavian mycosis fungoides study group. Bull Cancer 1977; 64:287-290.
5. Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA 1988; 260:42-46.
6. Tycko B, Sklar J. Chromosomal translocations in Iymphoid neoplasia: a reappraisal of the recombinase model. Cancer Cells 1990; 2:1-8.
7. Shapiro PE, Warburton D, Berger CL, et al. Clonal chromosomal abnormalities in cutaneous T-cell lymphoma. Cancer Genet Cytogenet 1987; 28:267-276.
8. MacKie R, Dick HM, de Sousa MB. Letter: HLA and mycosis fungoides. Lancet 1976; 1:1179.
9. Schuppli R. Is mycosis fungoides an "immunoma"? Dermatologica 1976; 153:1-6.
10. Greene MH, Dalager NA, Lamberg SI, et al. Mycosis fungoides: epidemiologic observations. Cancer Treat Rep 1979; 63:597-606.
11. Tuyp E, Burgoyne A, Aitchison T, et al. A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol 1987; 123:196-200.
12. Whittemore AS, Holly EA, Lee IM, et al. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst 1989; 81:1560-1567.
13. Weinstock MA. A registry-based case-control study of mycosis fungoides. Ann Epidemiol 1991; 1:533-539.
14. Kantor AF, Curtis RE, Vonderheid EC, et al. Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 1989; 63:1612-1615.
15. Dummer R, Nestle F, Wiede J, et al. Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell Iymphomas. Eur J Dermatol 1991 ; 1:135-138.
16. Boni R, Davis-Daneshfar A, Burg G, et al. No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol 1996; 134:282-284.
17. Dummer R, Kohl O, Gillessen J, et al. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol 1993; 129:433-436.
18. Dummer R, Heald PW, Nestle FO, et al. Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 1996; 88:1383-1389.
19. Burg G, Dummer R, Kerl H. Classification of cutaneous lymphomas. Dermatol Clin 1994; 12:213-217.
20. Stansfeld A, Diebold J, Noel H. Updated Kiel classification for lymphomas. Lancet 1988; 372:292-293.
21. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49:2112-2135.
22. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997: 90:354-371.
23. Burg G, Kempf W, Haeffner A, et al. Cutaneous lymphomas. Curr Probl Dermatol 1997; 9:137-204.
24. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-1392.
25. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994; 103:34-41.
26. Burg G, Dummer R. Small plaque (digitate) parapsoriasis is an 'abortive cutaneous T-cell lymphoma' and is not mycosis fungoides. Arch Dermatol 1995; 131:336-338.
27. Schmid MH, Bird P, Dummer R, et al. Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. Arch Dermatol 1999; 135:1204-1208.
28. Rickert S, Becker J, Brocker E, et al. Krankheitsverarbeitung bei Patienten mit kutanen malignen Lymphomen. Hautarzt 1999; 50:S69.
29. Dummer R, Michie SA, Kell D, et al. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cuton Pathol 1995; 22:11-17.
30. Kaye FJ, Bunn PA Jr., Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321:1784-1790.